循环瘤DNA:固体瘤中的泛癌生物标志物,具有预后和预测价值
Nadia Hitchen1, Adel Shahnam1, Jeanne Tie2,1
1Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;
Annual review of medicine
|November 21, 2024
概括
循环瘤DNA (ctDNA),一种液体活检,显示出癌症管理的前景. 这种生物标志物有助于早期检测,监测治疗,并预测固体瘤的结果.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 分子诊断学 分子诊断学
背景情况:
- 循环瘤DNA (ctDNA) 或液体活检是固体瘤的重要生物标志物.
- 它为局部癌症和晚期癌症提供了预后和指导治疗决策的潜力.
研究的目的:
- 审查目前关于ctDNA在治疗早期和晚期固体瘤中的临床功效的证据.
- 突出ctDNA在癌症治疗的各个方面所扮演的角色,包括癌症的检测,监测和治疗选择.
主要方法:
- 对ctDNA的现有科学文献和临床研究的审查.
- 对ctDNA测量技术方法的评估,例如下一代测序和滴滴数字PCR.
主要成果:
- ctDNA对于早期癌症检测,最小残留疾病评估,复发监测和治疗监测有价值.
- 与放射学方法相比,它的短半衰期提供了更为动态的疾病洞察力.
- 临床准确性受到ctDNA检测方法固有的生物和技术因素的影响.
结论:
- ctDNA是瘤学中一个多功能和有前途的生物标志物.
- 它的应用涵盖了癌症护理的连续性,从早期检测到先进的疾病管理.
- 进一步的研究和ctDNA分析的标准化对于最大限度地提高其临床影响至关重要.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


